Loyse Hippolyte1, Anne M Maillard1, Borja Rodriguez-Herreros2, Aurélie Pain1, Sandra Martin-Brevet2, Carina Ferrari3, Philippe Conus3, Aurélien Macé4, Nouchine Hadjikhani5, Andres Metspalu6, Anu Reigo6, Anneli Kolk7, Katrin Männik8, Mandy Barker9, Bertrand Isidor10, Cédric Le Caignec11, Cyril Mignot12, Laurence Schneider13, Laurent Mottron14, Boris Keren15, Albert David10, Martine Doco-Fenzy16, Marion Gérard17, Raphael Bernier18, Robin P Goin-Kochel19, Ellen Hanson20, LeeAnne Green Snyder21, Franck Ramus22, Jacques S Beckmann23, Bogdan Draganski24, Alexandre Reymond25, Sébastien Jacquemont26. 1. Service de Génétique Médicale, University of Lausanne, Lausanne, Switzerland. 2. Service de Génétique Médicale, University of Lausanne, Lausanne, Switzerland; LREN-Département des Neurosciences Cliniques, University of Lausanne, Lausanne, Switzerland. 3. Department of Psychiatry, University of Lausanne, Lausanne, Switzerland. 4. Department of Medical Genetics, University of Lausanne, Lausanne, Switzerland; SIB Swiss Institute of Bioinformatics, University of Lausanne, Lausanne, Switzerland. 5. Brain Mind Institute, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland. 6. Department of Genetics, Tartu University Hospital, Tartu, Estonia. 7. United Laboratories, and Children's Clinic, Department of Neurology and Neurorehabilitation, Tartu University Hospital, Tartu, Estonia. 8. Center for Integrative Genomics, University of Lausanne;Lausanne, Switzerland; Department of Genetics, Tartu University Hospital, Tartu, Estonia. 9. CERY Hospital, Department of Child Psychiatry, University of Lausanne, Lausanne, Switzerland. 10. Service de Génétique Médicale, CHU-Nantes, Nantes. 11. Service de Génétique Médicale, CHU-Nantes, Nantes; Inserm UMR957, Faculté de Médecine, Nantes. 12. Department of Genetics and Cytogenetics, Unité fonctionnelle de génétique clinique, Groupe Hospitalier Pitié Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France; Centre de Référence "Déficiences intellectuelles de causes rares" and Groupe de Recherche Clinique "Déficience intellectuelle et autisme", UPMC, Paris, France. 13. SUPEA, and Service of Neuropsychology and Neurorehabilitation, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland. 14. Département de Psychiatrie, Université de Montréal and Hôpital Rivière des Prairies, Montreal, Quebec, Canada. 15. Department of Genetics and Cytogenetics, Unité fonctionnelle de génétique clinique, Groupe Hospitalier Pitié Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France. 16. Service de Génétique, CHU, Reims. 17. Department of Genetics and Cytogenetics, Unité fonctionnelle de génétique clinique, Groupe Hospitalier Pitié Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France; Département de Génétique, Hôpital Robert Debré, Université Paris VII-Paris Diderot, Paris, France. 18. Department of Psychiatry and Behavioral Science, University of Washington, Seattle, Washington. 19. Department of Pediatrics, Psychology Section, Baylor College of Medicine, Houston, Texas. 20. Department of Psychiatry, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. 21. Clinical Research Associates, New York, New York. 22. Laboratoire de Sciences Cognitives et Psycholinguistique, Département d'Etudes Cognitives, Ecole Normale Supérieure, EHESS, CNRS, PSL Research University, Paris, France. 23. Service de Génétique Médicale, University of Lausanne, Lausanne, Switzerland; SIB Swiss Institute of Bioinformatics, University of Lausanne, Lausanne, Switzerland. 24. LREN-Département des Neurosciences Cliniques, University of Lausanne, Lausanne, Switzerland; Department of Neurology (BD), Max-Planck Institute for Human Cognitive and Brain Science, Leipzig, Germany. 25. Center for Integrative Genomics, University of Lausanne;Lausanne, Switzerland. 26. Service de Génétique Médicale, University of Lausanne, Lausanne, Switzerland. Electronic address: sebastien.jacquemont@umontreal.ca.
Abstract
BACKGROUND: Deletions and duplications of the 16p11.2 BP4-BP5 locus are prevalent copy number variations (CNVs), highly associated with autism spectrum disorder and schizophrenia. Beyond language and global cognition, neuropsychological assessments of these two CNVs have not yet been reported. METHODS: This study investigates the relationship between the number of genomic copies at the 16p11.2 locus and cognitive domains assessed in 62 deletion carriers, 44 duplication carriers, and 71 intrafamilial control subjects. RESULTS: IQ is decreased in deletion and duplication carriers, but we demonstrate contrasting cognitive profiles in these reciprocal CNVs. Deletion carriers present with severe impairments of phonology and of inhibition skills beyond what is expected for their IQ level. In contrast, for verbal memory and phonology, the data may suggest that duplication carriers outperform intrafamilial control subjects with the same IQ level. This finding is reminiscent of special isolated skills as well as contrasting language performance observed in autism spectrum disorder. Some domains, such as visuospatial and working memory, are unaffected by the 16p11.2 locus beyond the effect of decreased IQ. Neuroimaging analyses reveal that measures of inhibition covary with neuroanatomic structures previously identified as sensitive to 16p11.2 CNVs. CONCLUSIONS: The simultaneous study of reciprocal CNVs suggests that the 16p11.2 genomic locus modulates specific cognitive skills according to the number of genomic copies. Further research is warranted to replicate these findings and elucidate the molecular mechanisms modulating these cognitive performances.
BACKGROUND: Deletions and duplications of the 16p11.2 BP4-BP5 locus are prevalent copy number variations (CNVs), highly associated with autism spectrum disorder and schizophrenia. Beyond language and global cognition, neuropsychological assessments of these two CNVs have not yet been reported. METHODS: This study investigates the relationship between the number of genomic copies at the 16p11.2 locus and cognitive domains assessed in 62 deletion carriers, 44 duplication carriers, and 71 intrafamilial control subjects. RESULTS: IQ is decreased in deletion and duplication carriers, but we demonstrate contrasting cognitive profiles in these reciprocal CNVs. Deletion carriers present with severe impairments of phonology and of inhibition skills beyond what is expected for their IQ level. In contrast, for verbal memory and phonology, the data may suggest that duplication carriers outperform intrafamilial control subjects with the same IQ level. This finding is reminiscent of special isolated skills as well as contrasting language performance observed in autism spectrum disorder. Some domains, such as visuospatial and working memory, are unaffected by the 16p11.2 locus beyond the effect of decreased IQ. Neuroimaging analyses reveal that measures of inhibition covary with neuroanatomic structures previously identified as sensitive to 16p11.2 CNVs. CONCLUSIONS: The simultaneous study of reciprocal CNVs suggests that the 16p11.2 genomic locus modulates specific cognitive skills according to the number of genomic copies. Further research is warranted to replicate these findings and elucidate the molecular mechanisms modulating these cognitive performances.
Authors: Julie Ouellette; Xavier Toussay; Cesar H Comin; Luciano da F Costa; Mirabelle Ho; María Lacalle-Aurioles; Moises Freitas-Andrade; Qing Yan Liu; Sonia Leclerc; Youlian Pan; Ziying Liu; Jean-François Thibodeau; Melissa Yin; Micael Carrier; Cameron J Morse; Peter Van Dyken; Christopher J Bergin; Sylvain Baillet; Christopher R Kennedy; Marie-Ève Tremblay; Yannick D Benoit; William L Stanford; Dylan Burger; Duncan J Stewart; Baptiste Lacoste Journal: Nat Neurosci Date: 2020-07-13 Impact factor: 24.884
Authors: Chris M Panzini; Daniel G Ehlinger; Adele M Alchahin; Yueping Guo; Kathryn G Commons Journal: J Neurochem Date: 2017-11-10 Impact factor: 5.372